Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Acuren Sees Q3 Sales $460.000M-$480.000M vs $483.005M Est

Author: Benzinga Newsdesk | September 30, 2025 08:23am
Acuren (NYSE:TIC) sees Q3 sales of $460.000 million-$480.000 million vs $483.005 million analyst estimate.

Posted In: TIC

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist